Recombinant Protein Vaccine Market Report

Europe Recombinant Protein Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 15, 2020
  • PAGES：185
  • REPORT CODE：GMM508904
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Recombinant Protein Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Recombinant Protein Vaccine Market Segmentations:

    By Player:

    • Boehringer-Ingelheim

    • Zoties

    • Plumbline Life Sciences

    • Sanofi

    • Novavax

    • Indian Immunologicals

    • GSK

    • Merck

    • Medicago

    • Elanco

    By Type:

    • Bacterial Cells Culture

    • Mammalian Cells Culture

    By End-User:

    • Human

    • Animal

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Protein Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Recombinant Protein Vaccine Market Size and Growth Rate of Bacterial Cells Culture from 2014 to 2026

    • 1.3.2 Europe Recombinant Protein Vaccine Market Size and Growth Rate of Mammalian Cells Culture from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Recombinant Protein Vaccine Market Size and Growth Rate of Human from 2014 to 2026

    • 1.4.2 Europe Recombinant Protein Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Recombinant Protein Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant Protein Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Bacterial Cells Culture

      • 3.4.2 Market Size and Growth Rate of Mammalian Cells Culture

    4 Segmentation of Recombinant Protein Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant Protein Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Recombinant Protein Vaccine for Human

      • 4.4.2 Market Size and Growth Rate of Recombinant Protein Vaccine for Animal

    5 Market Analysis by Major Regions

    • 5.1 Europe Recombinant Protein Vaccine Production Analysis by Top Regions

    • 5.2 Europe Recombinant Protein Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Recombinant Protein Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Recombinant Protein Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Recombinant Protein Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Recombinant Protein Vaccine Landscape Analysis

    • 7.1 Germany Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    8. UK Recombinant Protein Vaccine Landscape Analysis

    • 8.1 UK Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 8.2 UK Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    9. France Recombinant Protein Vaccine Landscape Analysis

    • 9.1 France Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 9.2 France Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    10. Italy Recombinant Protein Vaccine Landscape Analysis

    • 10.1 Italy Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    11. Spain Recombinant Protein Vaccine Landscape Analysis

    • 11.1 Spain Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    12. Poland Recombinant Protein Vaccine Landscape Analysis

    • 12.1 Poland Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    13. Russia Recombinant Protein Vaccine Landscape Analysis

    • 13.1 Russia Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Recombinant Protein Vaccine Landscape Analysis

    • 14.1 Switzerland Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    15. Turkey Recombinant Protein Vaccine Landscape Analysis

    • 15.1 Turkey Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Recombinant Protein Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Recombinant Protein Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Recombinant Protein Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Recombinant Protein Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Recombinant Protein Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Recombinant Protein Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Recombinant Protein Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Recombinant Protein Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Recombinant Protein Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Recombinant Protein Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Recombinant Protein Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Boehringer-Ingelheim

      • 19.1.1 Boehringer-Ingelheim Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Zoties

      • 19.2.1 Zoties Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Plumbline Life Sciences

      • 19.3.1 Plumbline Life Sciences Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sanofi

      • 19.4.1 Sanofi Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novavax

      • 19.5.1 Novavax Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Indian Immunologicals

      • 19.6.1 Indian Immunologicals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 GSK

      • 19.7.1 GSK Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Merck

      • 19.8.1 Merck Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Medicago

      • 19.9.1 Medicago Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Elanco

      • 19.10.1 Elanco Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 89 Figures and 110 Tables)

    • Figure Product Picture

    • Figure Europe Recombinant Protein Vaccine Market Size and Growth Rate of Bacterial Cells Culture from 2014 to 2026

    • Figure Europe Recombinant Protein Vaccine Market Size and Growth Rate of Mammalian Cells Culture from 2014 to 2026

    • Figure Europe Recombinant Protein Vaccine Market Size and Growth Rate of Human from 2014 to 2026

    • Figure Europe Recombinant Protein Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • Figure Germany Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Recombinant Protein Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Recombinant Protein Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Recombinant Protein Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant Protein Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Recombinant Protein Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Bacterial Cells Culture

    • Figure Market Size and Growth Rate of Mammalian Cells Culture

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Recombinant Protein Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Recombinant Protein Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Human

    • Figure Market Size and Growth Rate of Animal

    • Table Europe Recombinant Protein Vaccine Production by Major Regions

    • Table Europe Recombinant Protein Vaccine Production Share by Major Regions

    • Figure Europe Recombinant Protein Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Recombinant Protein Vaccine Consumption by Major Regions

    • Table Europe Recombinant Protein Vaccine Consumption Share by Major Regions

    • Table Germany Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table France Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Recombinant Protein Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table UK Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table France Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Protein Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Protein Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Protein Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Recombinant Protein Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Boehringer-Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer-Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer-Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer-Ingelheim

    • Table Product and Service Introduction of Boehringer-Ingelheim

    • Table Company Profile and Development Status of Zoties

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zoties

    • Figure Sales and Growth Rate Analysis of Zoties

    • Figure Revenue and Market Share Analysis of Zoties

    • Table Product and Service Introduction of Zoties

    • Table Company Profile and Development Status of Plumbline Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Plumbline Life Sciences

    • Figure Sales and Growth Rate Analysis of Plumbline Life Sciences

    • Figure Revenue and Market Share Analysis of Plumbline Life Sciences

    • Table Product and Service Introduction of Plumbline Life Sciences

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Novavax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

    • Figure Sales and Growth Rate Analysis of Novavax

    • Figure Revenue and Market Share Analysis of Novavax

    • Table Product and Service Introduction of Novavax

    • Table Company Profile and Development Status of Indian Immunologicals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indian Immunologicals

    • Figure Sales and Growth Rate Analysis of Indian Immunologicals

    • Figure Revenue and Market Share Analysis of Indian Immunologicals

    • Table Product and Service Introduction of Indian Immunologicals

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Medicago

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicago

    • Figure Sales and Growth Rate Analysis of Medicago

    • Figure Revenue and Market Share Analysis of Medicago

    • Table Product and Service Introduction of Medicago

    • Table Company Profile and Development Status of Elanco

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elanco

    • Figure Sales and Growth Rate Analysis of Elanco

    • Figure Revenue and Market Share Analysis of Elanco

    • Table Product and Service Introduction of Elanco

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US